Clinical Study Results
Did any adverse reactions happen in this study?
The adverse reactions that the participant had during Part 2 of the study are not in this summary.
Because there was only 1 participant in Part 2, leaving this information out helps protect their
identity.
Part 1 Part 3 Overall
(out of 35 (out of 17 (out of 52
participants) participants) participants)
How many participants had adverse
80.0% (28) 94.1% (16) 84.6% (44)
reactions in this study?
How many participants had serious
28.6% (10) 17.6% (3) 25.0% (13)
adverse reactions in this study?
How many participants left the study
2.9% (1) 0% (0) 1.9% (1)
because of adverse reactions?
What serious adverse reactions happened during this study?
Overall, the most common serious adverse reaction was high fever. This happened in 15.4% of
participants. This was 8 out of 52 participants.
There were 1.9% of participants who died during the study, which the study doctors thought
might be related to the treatment. This was 1 out of 53 participants. This was the participant from
Group 9 in Part 3 who had a DLT.
Part 1
There were 28.6% participants who had at least 1 serious adverse reaction. This was 10 out of
35 participants.
• 22.9% of participants had a high fever. This was 8 out of 35 participants. This happened in
Groups 1, 2, 3, and 6.
• 2.9% of participants had a fast heart rate. This was 1 out of 35 participants. This happened in Group 1.
• 2.9% of participants had vomiting. This was 1 out of 35 participants. This happened in Group 1.
• 2.9% of participants had chills. This was 1 out of 35 participants. This happened in Group 6.
• 2.9% of participants had a flu-like illness. This was 1 out of 35 participants. This happened in Group 6.
• 2.9% of participants had a nodule. This was 1 out of 35 participants. This happened in Group 6.
• 8.6% of participants had a strong inflammatory reaction in the whole body due to an infection or
disease. This was 3 out of 35 participants. This happened in Groups 1, 2, and 5.
• 2.9% of participants had a seizure. This was 1 out of 35 participants. This happened in Group 1.
• 2.9% of participants had difficulty breathing. This was 1 out of 35 participants. This happened in
Group 6.
9